Evidence map›Paper›PMID 33195251›Full record

ArticleFrontiers in cell and developmental biology2020

Loss of β-Cytoplasmic Actin in the Intestinal Epithelium Increases Gut Barrier Permeability

Susana Lechuga, Nayden G Naydenov, Alex Feygin, Michael Cruise, James M Ervasti, Andrei I Ivanov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Alterations of actin in aging.Journal of cell science · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Autism-Associated Gut Microbiota-DerivedPathogens (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Susana LechugaDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Nayden G NaydenovDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Alex FeyginSchool of Nursing, Virginia Commonwealth University School of Nursing, Richmond, VA, United States.
Michael CruiseDepartment of Pathology, Cleveland Clinic Foundation, Cleveland, OH, United States.
James M ErvastiDepartment of Biochemistry and Molecular Biology, University of Minnesota Medical School, Minneapolis, MN, United States.
Andrei I IvanovDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Cleveland Clinic · USUniversity of Minnesota Medical Center · USVirginia Commonwealth University · US

Funding

Costamere Defects in Muscular DystrophiesR01AR049899 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI ERVASTI, JAMES M · 2005 to 2025
$8.2M
Actomyosin cytoskeleton and the regulation of intestinal eipithelial barrierR01DK108278 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI IVANOV, ANDREI IVANOVICH · 2016 to 2019
$1.4M
NIAMS NIH HHS R01 AR049899NIDDK NIH HHS R01 DK108278
6 · The paper itself

Abstract

Intestinal epithelial barrier is critical for the maintenance of normal gut homeostasis and disruption of this barrier may trigger or exaggerate mucosal inflammation. The actin cytoskeleton is a key regulator of barrier structure and function, controlling the assembly and permeability of epithelial adherens and tight junctions. Epithelial cells express two actin isoforms: a β-cytoplasmic actin and γ-cytoplasmic actin. Our previous

Indexed as

actin isoformsadherens junctionsbarriercells deathcolitiscytoskeletonmucosal inflammationtight junctions

Identifiers

PMID33195251
PMCPMC7644907
OpenAlexW3094527567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.